Will King vs. Burwell Tear Down the Health Care Law?
Quick answer: No…. King vs. Burwell is the case now before the Supreme Court, currently scheduled to be heard on March 4th, 2015. The Court will consider whether subsidies that
Impact:Physicians may hear more concerns from patients regarding the cost of filling their prescriptions. Manufacturers may hear negative publicity because patients feel like the cost is too high (though the drug’s list price didn’t change). Higher copays will make the drug company’s Patient Assistance Programs (PAP) more important in 2015. Coupled with the increase in enrollment being seen on the Exchanges, physicians and their staff will have more reason to make these programs available to their patients, and manufacturers will have more reason to promote those programs as widely as possible.
Quick answer: No…. King vs. Burwell is the case now before the Supreme Court, currently scheduled to be heard on March 4th, 2015. The Court will consider whether subsidies that
Subscribe to receive updates on the latest marketplace trends impacting pharma
*required fields